1.Clustered microcalcifications on mammogram: Loss of microcalcifications during tissue processing? radiologic-pathologic correlation.
Hy Young CHOI ; Gyeong Yeob GONG ; Deok Hee LEE ; Hyun Kyung SUNG
Journal of the Korean Radiological Society 1993;29(3):541-546
Mammography is the only examination capable of depicting malignant calcifications in breast. In some instances calcifications evident in mammogram and specimen mammograms are not observed in the histologic specimen. Therefore, wer retrospectively analyzed 27 cases in which hook-guided wire localization and biopsy had been performed to determine if microcalcifications were lost during histopathologic processing. Calcium was apparently lost during preparation of the block in about 7% of the cases and after slide preparation in about 11%, for a total possible loss of 18%. The authors recommend a protocol for avoiding these loss that involves performance of a more comprehensive examination of histologic sections by the pathologist and radiographic reexamination of paraffin-embedded tissue blocks with subsequent step sectioning by the pathologist.
Biopsy
;
Breast
;
Calcium
;
Mammography
;
Retrospective Studies
2.Stomach Cancer Arising from Remmnant Stomach 14 Years after Gastrectomy of EGC Type I (m).
U Chang CHOI ; Kyung Hee KIM ; Kwan Sik LEE ; Young Myoung MOON ; Hy De LEE ; Hyeon Joo JEONG
Korean Journal of Gastrointestinal Endoscopy 1989;9(1):25-27
Recently therapeutic efficacy of stomach cancer was greatly improved due to early diagnosis and irnproved diagnostic and therapeutic modalities. Especially in early gastric cancer, 5 year survival rate is near 100%. Recarrence of early gastric cancer after curative surgery is rarely reported. Recently authors experienced one case of recurrent stomach cancer arising from remmnant stomach 14 years after gastrectomy of EGC type I(m), so we reports it here with review of literatures.
Early Diagnosis
;
Gastrectomy*
;
Stomach Neoplasms*
;
Stomach*
;
Survival Rate
3.Preventive Effects of Zoledronic Acid on Bone Metastasis in Mice Injected with Human Breast Cancer Cells.
Joon JEONG ; Kyung Sun LEE ; Yang Kyu CHOI ; Young Ju OH ; Hy De LEE
Journal of Korean Medical Science 2011;26(12):1569-1575
Bisphosphonates are used routinely to reduce bone-related events in breast cancer patients with bone metastasis. We evaluated the effects of zoledronic acid, a third generation, nitrogen-containing bisphosphonate, to prevent bone metastasis in breast cancer. Zoledronic acid or vehicle alone was administered to nude mice either simultaneously or after intracardiac injection of human breast cancer MDA-MB-231 cells. Nude mice treated with zoledronic acid at early time points showed a lower incidence of bone metastases than did vehicle-treated nude mice, but these differences were not statistically significant. Only 37.5% of mice treated with zoledronic acid at the time of tumor cell inoculation developed bone metastases compared to over 51.8% of mice receiving vehicle alone (P = 0.304). Cell count of apoptosis confirmed by immunohistochemical staining in metastatic bone tissue significantly increased in the zoledronic acid-treated groups compared to non-treated group (1,018.3 vs 282.0; P = 0.046). However, metastatic tumor cells, which invade soft tissue around the bone, did not show extensive apoptosis; there were no differences between the zoledronic acid-treated and control groups. These results suggest that zoledronic acid increases apoptosis of metastatic breast tumor cells in the bone and could therefore reduce metastatic tumor burden. These results support the use of zoledronic acid to reduce the incidence of bone metastasis in breast cancer.
Animals
;
Apoptosis/drug effects
;
Bone Density Conservation Agents/pharmacology
;
Bone Neoplasms/prevention & control/*secondary
;
Bone and Bones/drug effects/pathology
;
Breast Neoplasms/*drug therapy/*pathology
;
Diphosphonates/*pharmacology
;
Female
;
Humans
;
Imidazoles/*pharmacology
;
Mice
;
Mice, Nude
;
Xenograft Model Antitumor Assays
4.A Study on Nucleus Segmentation of Uterine Cervical Pap-Smears using Multi Stage Segmentation Technique.
Ho Young KIM ; Sun A KIM ; Yea Chan CHOI ; Baek Sop KIM ; Hy Sook KIM ; Sung Euu NAMKOONG
Journal of Korean Society of Medical Informatics 1999;5(1):89-97
The region segmentation of the pap-smear image is known to be a difficult and important part in the automatic image recognition system. Both the pixel based methods(thresholding) and the region based methods(split and merge, region growing and edge detection) are widely used for segmentation of the nucleus, cytoplasm and background in the pap-smear images. The pixel based methods are relatively fast, but not accurate, while the region based methods are accurate, but slow. This paper proposes a multistage segmentation strategy which uses thresholding and incremental color clustering methods to reduce computation time while not sacrificing accuracy. Proposed method consists of three stages. The first stage uses global thresholding method to search nucleus blob position, and the second stage employs incremental color clustering with color information. The final stage segments unsuitable nuclei using thresholding method after calculating suitability for each extracted nucleus blob. The proposed segmentation method is tested under various error measures. The experimental results showed that each stage of the proposed method reduced specific error measures: The second stage reduced false negative error and the third stage false positive error.
Cytoplasm
5.Evaluation of HER2/neu Status by Real-Time Quantitative PCR in Breast Cancer.
Young Ree KIM ; Jong Rak CHOI ; Kyung Soon SONG ; Woo Hee CHONG ; Hy De LEE
Yonsei Medical Journal 2002;43(3):335-340
Over-expression of the human epidermal growth factor receptor-2 (HER2/neu) has been observed in many cancers, and is associated with a poor prognosis. Recent adjuvant treatment with anti-HER2 monoclonal antibodies in breast cancer has increased the demand for an evaluation of the HER2/neu status in breast cancer. The aim of this study was to investigate the HER2/neu status in breast cancer by a real-time quantitative polymerase chain reaction (PCR) method using LightCycler (Roche Diagnostics, Mannheim, Germany). DNA samples from the fresh tumor tissues of 27 patients with breast cancer were analyzed in parallel using immunohistochemistry (IHC) and the other prognostic parameters including estrogen receptor, progesterone receptor, cytokeratin, and DNA ploidy. Ten (37%) out of 27 cases tested were positive for HER2/neu, while 16 (73%) out of 22 tested positive through an IHC study. The correlation between the DNA aneuploidy and the positive results for HER2/neu were only observed using the real-time PCR method (p < 0.05). There was no significant correlation between the HER2/neu status and the S-phase fractions of the DNA ploidy or other parameters. This study demonstrated that there is marked discordance in the results for the HER2/neu status according to the various methods used. Real-time quantitative PCR for HER2/neu appears to be clinically useful due to its simplicity and ability to produce rapid results.
Breast Neoplasms/*metabolism
;
Female
;
Human
;
Protein Isoforms/metabolism
;
Receptor, Epidermal Growth Factor/*metabolism
;
*Reverse Transcriptase Polymerase Chain Reaction
6.Clinical Report of Intravascular Papillary Endothelial Hyperplasia.
Jeong Woo LEE ; Ho Yun CHUNG ; Seok Jong LEE ; Gui Rak KIM ; Kang Young CHOI ; Jung Dug YANG ; Byung Chae CHO
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2010;37(3):239-244
PURPOSE: Intravascular papillary endothelial hyperplasia(IPEH), also known as Masson's pseudoangiosarcoma, is a rare disease which is now considered as a reactive process of the endothelium rather than a benign neoplasm. It can occur in any blood vessels in the body but more common in the head and neck region as a solitary, often tender, bluish or reddish nodule. IPEH is characterized by the development of endothelial-lined papillary projections in a vascular lumen, usually associated with thrombotic material, the endothelial cells in the papillary structures showing only slight atypia and occasional mitotic Figures, the absence of tissue necrosis. METHODS: 8 patients with IPEH were enrolled in the study from 2002 to 2007. All 8 lesions were surgically excised for histopathologic diagnosis. RESULTS: 4 patients were female. The duration of the lesions ranged from 3 months to 15 years. The tumors were first noted between the ages of 20 and 72 years. 4 patients had lesions on the head; 2 on the toe; 1 on the back; and 1 on the finger, respectively. All lesions were solitary, ranged in size from 2mm to 27 mm. There were no recurrences. CONCLUSION: The clinical appearance of IPEH is not specific, presented as a primary neoplasm, and the diagnosis can be established by microscopic examination. Complete surgical excision is the best choice of therapy for patients with IPEH, and is both diagnostic and curative. Awareness of this lesion will prevent incorrect diagnosis and overly aggressive treatment.
Blood Vessels
;
Endothelial Cells
;
Endothelium
;
Female
;
Fingers
;
Head
;
Humans
;
Hyperplasia
;
Neck
;
Necrosis
;
Rare Diseases
;
Recurrence
7.Clinical Experience of the Klippel-Trenaunay Syndrome.
Hyung Min SUNG ; Ho Yun CHUNG ; Seok Jong LEE ; Jong Min LEE ; Seung HUH ; Jeong Woo LEE ; Kang Young CHOI ; Jung Dug YANG ; Byung Chae CHO
Archives of Plastic Surgery 2015;42(5):552-558
BACKGROUND: The Klippel-Trenaunay syndrome (KTS) is characterized by three clinical features, namely cutaneous capillary malformations, venous malformations, and soft tissue and/or bony hypertrophy of the extremities. The varied manifestations are attributed to the unpredictable clinical nature and prognosis of the syndrome. To elucidate the clinical characteristics of this disease, we reviewed a relatively large number of KTS patients who presented to our vascular anomalies center. METHODS: We conducted a retrospective study with 19 patients who were diagnosed with KTS and treated in our vascular anomalies clinic between 2003 and 2014, and examined their demographic characteristics, their clinical features, and the treatments administered. RESULTS: The sex distribution was balanced, with 9 (47%) males and 10 (53%) females. The mean follow-up period was 4.1 years (range, 7 months-9 years). Most of the patients received conservative treatments such as medication or physiotherapy. Compression therapies such as wearing of elastic garments/bandages were also administered, and surgical interventions were considered only when the patients became excessively symptomatic. Other treatments included laser therapy and sclerotherapy, and all the treatments were adjusted according to each case, tailored to the conditions of the individual patients. CONCLUSIONS: KTS is an extremely rare, multifactorial disorder that induces widely varied symptoms. Because of this unique feature, plastic surgeons, when not careful, tend to attach a one-sided importance to typical symptoms such as limb hypertrophy or capillary malformation and thus overlook other symptoms and clinical features. KTS can be suspected in all infants who show capillary malformations or limb hypertrophy and require a multi-disciplinary approach for comprehensive management.
Capillaries
;
Extremities
;
Female
;
Follow-Up Studies
;
Humans
;
Hypertrophy
;
Infant
;
Klippel-Trenaunay-Weber Syndrome*
;
Laser Therapy
;
Male
;
Plastics
;
Prognosis
;
Retrospective Studies
;
Sclerotherapy
;
Sex Distribution
;
Vascular Malformations
8.Correlation Of Human Papillomavirus Infection and Postmenopausal Squamous Atypia in Cervical Cytology.
Yi Kyeong CHUN ; In Gul MOON ; Sung Ran HONG ; Hye Sun KIM ; Jong Sun CHOI ; Ji Young PARK ; Jong Sook PARK ; Tae Jin KIM ; Hy Sook KIM
Korean Journal of Cytopathology 2004;15(2):81-85
Postmenopausal squamous atypia (PSA) is a phenomenon characterized by cellular alterations mimicking condyloma in the uterine cervix of postmenopausal women. It is not associated with human papillomavirus (HPV) infection. The aim of this study is to correlate findings with HPV infection and the cytohistologic findings of PSA. Eighty-three smears from postmenopausal women, initially interpreted as ASCUS and low-grade squamous intraepithelial lesions(LSIL), were reviewed according to the criteria of PSA. Fifty-eight cases were subsequently reclassified as PSA. Forty cases categorized as PSA were available for HPV-DNA detection by a nested polymerase chain reaction. Eight of these 40 cases(20%) showed biopsy-proven LSIL lesions. The HPV-DNA was detected in 42.5%(17/40), compared to 25%(5/20) of control cases. The HPV-DNA detection rate of biopsy-proven LSIL was 62.5%(5/8). It has been concluded that cytologic differential diagnosis of PSA from LSIL is difficult due to because of poor histologic and viral correlation.
Cervix Uteri
;
Diagnosis, Differential
;
Female
;
Humans*
;
Papillomavirus Infections*
;
Polymerase Chain Reaction
9.Sensitivity of AutoPap Primary Screening System with Location-Guided Screening in Uterine Cervical Cytology.
Jong Sun CHOI ; Hoi Sook JANG ; Hy Sook KIM ; Yi Kyeong CHUN ; Hye Sun KIM ; Ji Young PARK ; In Sou PARK ; Sung Ran HONG
Korean Journal of Cytopathology 2003;14(2):60-65
OBJECTIVE: The sensitivity of the AutoPap Primary Screening System with Location-Guided Screening (AutoPap LGS) for identifying atypical cells in cervicovaginal smears was evaluated. METHODS: Two hundred forty one slides with atypical cervical cytology randomly sampled were rescreened both manually and by the AutoPap LGS. The AutoPap LGS localized the atypical cells as 15 fields of view(FOVs), which were reexamined by manual review. The sensitivity was also evaluated in accordance with the cellularity of the smears. RESULTS: The AutoPap LGS successfully processed 232 out of 241 slides. The sensitivity of the AutoPap LGS identifying the atypical cells in successfully processed slides was 97.4%(226/232). The false negative rate was 2.6%(6/232). There was no false negative case in high grade squamous intraepithelial lesion (HSIL) or squamous cell carcinoma(SCC) smears in the AutoPap LGS. The FOVs localized the diagnostic-atypical cells in 97.8%(221/226). The number of diagnostic-atypical FOVs was increased in higher-degree of atypical cytology. The AutoPap LGS localized the atypical cells in 100% of adequately cellular smears and in 92.5% even in low cellular smears. CONCLUSION: The AutoPap LGS showed relatively good sensitivity to detect atypical cells. It can be a valuable system to localize atypical cells, especially in HSIL or cancer slides, even in smears with low cellularity.
Mass Screening*
;
Vaginal Smears
10.Experimental Assessment of Hemostatic Agents: Comparison with New Developed Chitosan-Based Material.
Young Kyoo CHO ; Sang Yun LEE ; Tae Jung KIM ; Hyun Ju LIM ; Eun Jung OH ; Soo Bok LEE ; Kang Young CHOI ; Jung Dug YANG ; Byung Chae CHO ; Ho Yun CHUNG
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2011;38(4):369-375
PURPOSE: Many hemostatic agents and dressings have been tested with variable degree of success. Chitosan has a positive charge, it attracts red blood cells, which have a negative charge. Our goal is to test the efficacy of new developed chitosan-based hemostatic materials in providing durable hemostasis in a high-flow arterial wound model. METHODS: We compared each group with SD rats motality tests and in vitro blood compatibility test by blood clotting index (BCI). We devided the SD rats into 6 groups (N =15) by type of hemostatic agents. A: 100% nonwoven chitosan (degree of the deacetylation: 90%). B: 50% N-acetylation on nonwoven of chitosan gel (degree of the deacetylation: 50%). C: 60% N-acetylation on nonwoven of chitosan ge (degree of the deacetylation: 40%)l. D: Cutanplast(R). E: HemCon(R) F: Gauze. In vivo test, a proximal arterial injury was created in unilateral femoral arteries of 90 anesthetized SD rats. Each materials was made same size and thickness then applied to the injury site for 3 minutes. In vitro test, we compared each group with BCI in human blood. RESULTS: In vivo test, group A showed lower motality rate of 46% than any other groups, Group B and C showed lower motality rate of 60% than group D and E's motality rate of 66%. In vitro test, BCI of group A (30.6 +/- 1.2) and B (29.3 +/- 1.0) were showed nearly about group D (29.1 +/- 1.8) and E (27.4 +/- 1.6). Group C (37.1 +/- 2.0) showed higher BCI than group A and B, it means group C decreased blood clotting. CONCLUSION: In conclusion, this study suggests a newly developed chitosan-based hemostatic materials induced durable hemostasis and increased blood clotting, and are considered as effective biologic hemostatic agents.
Animals
;
Bandages
;
Blood Coagulation
;
Chitosan
;
Erythrocytes
;
Fees and Charges
;
Femoral Artery
;
Hemostasis
;
Humans
;
Rats